6-aminomethyl-3-methyl-4h-1,2,4-benzothiadiazine 1,1-dioxide has been researched along with beta-alanine in 1 studies
Studies (6-aminomethyl-3-methyl-4h-1,2,4-benzothiadiazine 1,1-dioxide) | Trials (6-aminomethyl-3-methyl-4h-1,2,4-benzothiadiazine 1,1-dioxide) | Recent Studies (post-2010) (6-aminomethyl-3-methyl-4h-1,2,4-benzothiadiazine 1,1-dioxide) | Studies (beta-alanine) | Trials (beta-alanine) | Recent Studies (post-2010) (beta-alanine) |
---|---|---|---|---|---|
25 | 0 | 0 | 3,177 | 207 | 1,807 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cooke, JE; Ghavanini, AA; Mathers, DA; McCarthy, SM; Puil, E | 1 |
1 other study(ies) available for 6-aminomethyl-3-methyl-4h-1,2,4-benzothiadiazine 1,1-dioxide and beta-alanine
Article | Year |
---|---|
Effects of the beta-amino acid antagonist TAG on thalamocortical inhibition.
Topics: Animals; Benzothiadiazines; beta-Alanine; Bicuculline; Dose-Response Relationship, Drug; Glycine; Inhibitory Postsynaptic Potentials; Kynurenic Acid; Membrane Potentials; Patch-Clamp Techniques; Protein Subunits; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Receptors, Glycine; Strychnine; Taurine; Thalamic Nuclei | 2009 |